Bioprinting human tissues

You may have heard the 3D printing technology, which can print everything from wrenches to aircraft parts. Have you heard bioprinting, which uses cells to "print" human tissues?

Organovo Holdings (ONVO) is just such a company, which develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company’s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. For example, Organovo can grow heart tissue and makes it to beat like a real heart. Eventually I think human organs can be "printed" for transplantation purposes. You can imagine what kind of the market it can be if doctors can print organs whenever there is a demand for transplant.

ONVO is kind of stock with a huge potential but it will certainly be very volatile! It may jump several times within a few weeks but may burst equally fast. See the chart below. It seems at the bottom at the moment. If you have the gut for its volatility, this may be the time to consider to get in.